Ultrasensitive c-protein greater than 10 is assessed as high risk in cardiovascular disease, which needs to be further evaluated in conjunction with other indicators and history. 1. Patients can be categorized for cardiovascular risk based on the level of ultrasensitive CRP: i.e., <1mg/L is relatively low risk, 1.0-3.0mg/L is moderate risk, >3.0mg/L is high risk, and concomitant anti-inflammatory and antithrombotic therapy is recommended, and >10mg/L suggests that other infections (bacterial or viral) may be present. 2. Ultrasensitive CRP and CRP are the same thing, there is no essential difference. Ordinary CRP test can’t give a specific value below 10mg/L, but can only show a generalized value of <10mg/L (≠normal), so we need a more sensitive test method such as ultrasensitive c-protein. 3. The two CRP detection methods are different, routine immunoturbidimetric method, and ultrasensitive using latex agglutination method, so the two tests are not comparable in value. 4. Ultrasensitive CRP is clinically used for the diagnosis and prediction of cardiovascular events, and can be used to sensitively differentiate between low-level inflammatory states, as well as for neonatal infections.